Literature DB >> 9851536

Subtypes of functional alpha1- and alpha2-adrenoceptors.

J R Docherty1.   

Abstract

In this review, subtypes of functional alpha1- and alpha2-adrenoceptors are discussed. These are cell membrane receptors, belonging to the seven transmembrane spanning G-protein-linked family of receptors, which respond to the physiological agonists noradrenaline and adrenaline. Alpha1-adrenoceptors can be divided into alpha1A-, alpha1B- and alpha1D-adrenoceptors, all of which mediate contractile responses involving Gq/11 and inositol phosphate turnover. A 4th alpha1-adrenoceptor, the alpha1L-, has been postulated to mediate contractions in some tissues, but its relationship to cloned receptors remains to be established. Alpha2-adrenoceptors can be divided into alpha2A-, alpha2B- and alpha2C-adrenoceptors, all of which mediate contractile responses. Prejunctional inhibitory alpha2-adrenoceptors are predominantly of the alpha2A-adrenoceptor subtype (the alpha2D-adrenoceptor is a species orthologue), although alpha2C-adrenoceptors may also occur prejunctionally. Although alpha2-adrenoceptors are linked to inhibition of adenylate cyclase, this may not be the primary signal in causing smooth muscle contraction; likewise, prejunctional inhibitory actions probably involve restriction of Ca2+ entry or opening of K+ channels. Receptor knock-out mice are beginning to refine our knowledge of the functions of alpha-adrenoceptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851536     DOI: 10.1016/s0014-2999(98)00682-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  67 in total

1.  Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens.

Authors:  V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation.

Authors:  E W Willems; L F Valdivia; P R Saxena; C M Villalón
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens.

Authors:  A Lavelle; V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Pharmacology and thermosensitivity of the dartos muscle isolated from rat scrotum.

Authors:  Alan Gibson; Adetokunbo Akinrinsola; Tejesh Patel; Arijit Ray; John Tucker; Ian McFadzean
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

5.  Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.

Authors:  Marcelo Campos; Paola de Lucena Morais; André S Pupo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-05       Impact factor: 3.000

6.  Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys.

Authors:  Stephen J Kohut; Peter A Fivel; Nancy K Mello
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

7.  Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.

Authors:  Daisuke Fukui; Xiao-Ping Yang; Shigetoshi Chiba
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

8.  Identification of functional alpha-adrenoceptor subtypes in the bovine female genital tract during different phases of the oestrous cycle.

Authors:  G Re; P Badino; R Odore; C Zizzadoro; P Ormas; C Girardi; C Belloli
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

9.  Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.

Authors:  C L Barr; K Wigg; G Zai; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

10.  alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.

Authors:  K Orito; M Kishi; T Imaizumi; T Nakazawa; A Hashimoto; T Mori; T Kambe
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.